The Week In Biopharma, June 13 – 17
Contract Development and Manufacturing (CDMO)
- Avid Bioservices and CRB Partner on Viral Vector Facility (USA)
- Cizzle Biotechnology Announces Strategic Agreement with the Behnke Group to Enhance U.S. Market Presence (UK/USA)
- WuXi ATU and Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel Cell Cancer Immunotherapies (China/USA)
- Exothera announces industrial scale AAV manufacturing collaboration with LogicBio Therapeutics and Polyplus (Belgium/USA/France)
- Pierre Fabre and Lonza Enter Manufacturing Agreement for W0180 Antibody Drug Product (France/Switzerland)
- Boston Scientific offers $230M for Korean maker of gastrointestinal and airway stents (USA/Korea)
- Koneksa teams with Aural Analytics to add speech analysis to digital biomarker offering (USA)
- SK pharmteco Expands Pharma Manufacturing Footprint (Ireland)
- Batavia Biosciences Expands HQ and R&D Services (Netherlands)
- Center for Breakthrough Medicines Accelerates Plans to Build the Largest Cell Therapy Manufacturing Operation in the World (USA)
- GTCR and Carlyle-Backed Resonetics Announces Acquisition of Agile MV (USA/Canada)
- ValGenesis Acquires 4Tune Engineering, Extends Product Portfolio with Best-in-Class Risk Management and Continuous Process Verification Software Platforms (India/Portugal)
- Piramal Pharma Solutions Expands API Capabilities in (India)
- ProBioGen & ValenzaBio Enter Second Service Agreement (Germany/USA)
- KBI Biopharma, Selexis Open Mammalian Development, Mfg. Facility in Geneva (USA/Switzerland)
- Elemental Machines introduces its Usage Solution, a novel product suite to enable more efficient biotech/pharma drug discovery and manufacturing (USA)
- BioCina announces opening of new GMP plasmid DNA manufacturing suite (Australia)
- Coave Therapeutics and ABL Enter Gene Therapy Collaboration (France/Korea)
- ten23 Unveils Major Expansion in Switzerland on swissfillon Site (Switzerland)
- Avid Bioservices Expands Process Development Capacity (USA)
- Charles River and ASC Therapeutics Expand Gene Therapy Manufacturing Partnership (USA)
Biopharma
- Fluent BioSciences and NanoCellect announce joint collaboration to improve resolution of single-cell RNA sequencing analysis of rare cell populations (USA)
- Scholar Rock raises $205M as 24-month data point to durability of SMA efficacy (USA)
- Sierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration (Canada)
- SKYRIZI® (risankizumab-rzaa) Receives FDA Approval as the First and Only Specific Interleukin-23 (IL-23) to Treat Moderately to Severely Active Crohn’s Disease in Adults (USA)
- Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Use in Patients with Bardet-Biedl Syndrome (USA)
- Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis (USA)
- Moleculin Announces Completion of First Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the (UK)
- Nordic Bioscience and Roche Diagnostics Strengthen Collaboration for Development of Biomarkers for Chronic Diseases (Denmark/Switzerland)
- Pfizer chisels off stake in Akero with $25M equity investment to support NASH dreams (USA)
- Humanigen, PCI Pharma Services Enter Lenzilumab Partnership (USA)
- Phanes Therapeutics announces FDA IND clearance for PT886, an anti-claudin18.2/anti-CD47 bispecific antibody being developed for patients with gastric, gastroesophageal junction, and pancreatic cancers (USA)
- Exelixis and BioInvent Establish Exclusive Option and License Agreement to Develop Novel Antibody-Based Immuno-Oncology Therapies (USA/Sweden)
- Vipergen and LEO Pharma Partner for DNA Encoded Library (DEL)-Based Drug Discovery for Dermatology Indications (Denmark)
- Omega Therapeutics Announces Submission of Investigational New Drug Application for OTX-2002, an Omega Epigenomic Controller, for MYC Driven Hepatocellular Carcinoma (USA)
- Boehringer Ingelheim signs Option to Acquire Trutino Biosciences (Germany/USA)
- RTK Group Announces Investment in Unravel Biosciences (USA)
- Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis (USA)
- With $1B already in for Dren Bio, Pfizer adds to pile in $65M financing (USA)
- Alnylam wins FDA approval of rare disease drug in step toward profitability (USA)
- Boston startup Elektrofi looks to make a big manufacturing push with new funding round (USA)
- Inspired by Scientist CEOs, Seattle Startup Talus Bioscience Lands $9.75M to Build Up Drug Discovery Platform (USA)
- FDA Approves First Systemic Treatment for Alopecia Areata (USA)
- Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement (USA)
- Veralox Therapeutics Announces Favorable Results of Phase 1 Studies of VLX-1005 in Development for Treatment of Heparin-Induced Thrombocytopenia (USA)
- Oxford BioTherapeutics Announces Research Collaboration with ImmunoGen to Develop Novel Antibody-Drug Conjugates (UK/USA)
- With stacked to-do list, ImCheck checks off next funding round, refueling with about $101M (France)
Artificial Intelligence
- DTx Leader Sidekick Enters Strategic Collaboration with Lilly to Support Patients with Breast Cancer (Iceland/USA)
- Paige, Janssen team up to launch AI-powered bladder cancer test (USA/Belgium)
- Aidoc nearly doubles funding with $110M haul for CT scan-reading AI (Israel)
- Enosis Therapeutics Generates Positive Results from World’s First Study of the Synergistic Application of Virtual Reality and Psychedelics (Australia)
- Digital pathology player Proscia procures $37M to expand its reach (USA)
- Able Innovations works to transform frontline healthcare with USD $6MM in funding (Canada)
- Ainnocence Launches Self-Evolving, Multi-Objective AI Drug Discovery Platform (USA)
- Lensar eyes launch of AR-assisted cataract surgery system after FDA clearance (USA)
- Ekso Bionics nabs FDA exoskeleton clearance for multiple sclerosis rehabilitation (USA)
- FDA clears digital tool to help diagnose autism in children as young as 16 months (USA)
- Sanofi taps AI firm Yseop to automate trial report writing (France)
